Skip to main content

Table 5 Risk of death and CA-125 changes after the treatment

From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

Variable HR 95%CI P
Change of CA-125 concentration
3 months after the treatment (U/ml)
< 0 1.00
0–5 1.62 0.84–3.11 0.15
> 5 3.83 1.47–10.00 0.0062
Change of CA-125 concentration
6 months after the treatment (U/ml)
< 0 1.00
0–5 0.972 0.483–1.956 0.937
> 5 3.1 1.53–6.31 0.0017